Edition:
India

Acasti Pharma Inc (ACST.OQ)

ACST.OQ on NASDAQ Stock Exchange Capital Market

0.99USD
21 Feb 2018
Change (% chg)

-- (--)
Prev Close
$0.99
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
132,790
52-wk High
$3.34
52-wk Low
$0.85

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.16 February 22 Feb 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 0 0 0 0
(2) OUTPERFORM 2 1 1 1
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.00 2.00 2.00 2.00

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Feb-18 1 0.00 0.00 0.00 --
Year Ending Feb-18 2 0.00 0.00 0.00 0.04
Year Ending Feb-19 2 3.24 6.49 0.00 0.06
Earnings (per share)
Quarter Ending Feb-18 1 -0.16 -0.16 -0.16 --
Year Ending Feb-18 2 -0.54 -0.29 -0.79 -0.77
Year Ending Feb-19 2 -0.35 -0.34 -0.37 -0.71

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Nov-17 0.00 0.00 0.00 0.00
Quarter Ending Nov-14 0.27 0.02 0.25 91.10
Earnings (per share)
Quarter Ending Nov-17 -0.25 -0.32 0.07 -26.42
Quarter Ending Nov-14 -0.27 0.25 0.52 -191.90

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Feb-18 0.00 0.00 -- -- --
Year Ending Feb-18 0.00 0.00 0.00 0.00 0.04
Year Ending Feb-19 3.24 3.24 0.00 0.00 0.06
Earnings (per share)
Quarter Ending Feb-18 -0.16 -0.16 -- -- --
Year Ending Feb-18 -0.54 -0.54 -0.29 -0.77 -0.77
Year Ending Feb-19 -0.35 -0.35 -0.37 -0.98 -0.71

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Feb-18 0 0 -- --
Year Ending Feb-18 0 0 0 0
Year Ending Feb-19 0 0 0 0
Earnings
Quarter Ending Feb-18 0 0 -- --
Year Ending Feb-18 0 0 0 0
Year Ending Feb-19 0 0 0 0